初代細胞培養の市場規模、シェア、動向分析レポート：製品別、分離方法別、細胞タイプ別、用途別、地域別、セグメント別予測、2024年～2030年

初代細胞培養市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の初代細胞培養市場規模は2030年までに115億9,000万米ドルに達し、2024年から2030年までのCAGRは13.3％で拡大すると予測されています。

個別化治療や精密治療に対する需要の高まりが、より正確で関連性の高いin vitroモデルの必要性を煽っています。初代細胞培養は、従来の細胞株と比較してヒトの生物学や生理学をより忠実に再現することができるため、疾患メカニズムの研究、創薬、治療法開発に不可欠なツールとなっています。研究者や製薬会社は、医薬品候補の成功率を向上させ、コストのかかる後期段階での失敗を減らし、最終的には患者により効果的で的を絞った治療を提供するために、初代細胞培養の重要性をますます認識しつつあります。

さらに、再生医療の分野では、損傷した組織や臓器の置換や修復を目指しており、初代細胞培養は、機能的組織の開発や工学化において重要な役割を果たしています。初代細胞は、組織構築物、オルガノイド、生体工学的インプラントなど、本来の組織の構造や機能を忠実に模倣したものを作製するために用いられています。これらの進歩は、組織移植、創傷治癒、変性疾患の治療などの再生医療治療に重要な意味を持っています。例えば、2023年4月、マウントサイナイは、新たな発見を育み、生命を脅かす疾患に対する新たな治療法を探求するために、再生医療のための新しい研究所を立ち上げました。再生医療への関心の高まりとヘルスケアに革命をもたらす可能性が、初代細胞培養への投資と研究の増加につながり、市場の成長を後押ししています。

COVID-19パンデミックは初代細胞培養産業に大きな影響を与えました。パンデミックはヘルスケアや研究を含む様々な産業を混乱させたが、ウイルスを理解し治療法を開発する上で初代細胞培養の重要な役割を浮き彫りにしました。初代細胞は、SARS-CoV-2感染のメカニズムの研究、抗ウイルス療法の試験、ワクチンの有効性の評価に役立っています。パンデミックは、世界中の研究者がCOVID-19関連の研究に注力する中で、初代細胞培養製品およびサービスの需要を加速させました。

さらに、市場参入企業の主な発展や産学連携の増加が世界市場を牽引しています。例えば、2023年1月には、Bio-TracとATCCが共同で、初代細胞培養の原理、オルガノイドとスフェロイド、その他の関連する細胞培養技術の概要を提供するトレーニングワークショップを実施しました。

初代細胞培養市場レポートハイライト

• 製品タイプ別では、試薬・サプリメントセグメントが2023年に37.7%のシェアを占めました。これは、特定の細胞タイプや研究用途に合わせた高品質の試薬・サプリメントが幅広く入手可能なためです。
• 分離方法別では、酵素分解分野が2023年に32.15%のシェアで市場を独占しました。この方法の利点は、培養物へのダメージが少ないこと、所要時間が比較的短いこと、サンプルの分取量が多いことなどです。
• 細胞タイプ別では、動物細胞セグメントが2022年に59.41%のシェアを占め、市場を独占しました。このセグメントの高成長は、この細胞タイプの汎用性、幅広い入手可能性、確立された研究プロトコールに起因しています。
• 北米は、高度に発達したヘルスケアインフラと有利な政府政策により、2023年には41.52%のシェアを獲得し、世界市場で確固たる地位を築いた。

目次

第1章 調査手法と範囲

第2章 初代細胞培養市場：エグゼクティブサマリー

• 市場スナップショット
• 製品と分離方法のスナップショット
• セルの種類と用途のスナップショット
• 競合情勢のスナップショット

第3章 初代細胞培養市場の変数、動向、および範囲

• 市場セグメンテーションと範囲
• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
• 市場促進要因分析
  • インビトロ検査および薬物スクリーニングにおける初代細胞培養製品の使用量の増加
  • 幹細胞治療と再生医療の需要の増加
  • がんやその他の慢性疾患の発生率の増加
  • 遺伝子工学プロトコルの進歩
  • 機能生物学および調査に対する調査資金の増加
• 市場抑制要因分析
  • 初代細胞の使用に関連する倫理的および規制上の懸念
  • 寿命が有限で、成長が遅く、取り扱いが重要
• 初代細胞培養市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTLE分析

第4章 初代細胞培養：製品の推定・動向分析

• 製品市場シェア、2023年と2030年
• セグメントダッシュボード
• 製品別の世界の初代細胞培養市場の見通し
• 市場規模と予測および動向分析、2018～2030年
  • 初代細胞
  • 試薬とサプリメント
  • メディア

第5章 初代細胞培養：分離方法の推定・動向分析

• 分離市場シェア、2023年と2030年
• セグメントダッシュボード
• 分離方法別の世界の初代細胞培養市場の見通し
• 市場規模と予測および動向分析、2018～2030年
  • 外植法
  • 酵素分解
  • 機械的分離
  • その他

第6章 初代細胞培養：細胞型の推定・動向分析

• セル型市場シェア、2023年および2030年
• セグメントダッシュボード
• 細胞タイプ別の世界の初代細胞培養市場の見通し
• 市場規模と予測および動向分析、2018～2030年
  • 動物細胞
  • ヒト細胞

第7章 初代細胞培養：用途の推定・動向分析

• 用途市場シェア、2023年と2030年
• セグメントダッシュボード
• 用途分野別の世界の初代細胞培養市場の見通し
• 市場規模と予測および動向分析、2018～2030年
  • 細胞および遺伝子治療の開発
  • ワクチンの製造
  • モデルシステム
  • ウイルス学
  • 出生前診断
  • その他

第8章 地域ビジネス分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• マーカーのサイズと予測トレンド分析、2018～2030：
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • 韓国
  • タイ
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
  • List of Key Distributors And Channel Partners
  • Key Customers
  • Key Company Market Share Analysis, 2023
  • Thermo Fisher Scientific, Inc.
  • Lonza
  • Merck
  • Corning Incorporated
  • Danaher
  • PromoCell GmbH
  • ATCC
  • FUJIFILM Irvine Scientific, Inc.
  • Mattek
  • Axol Bioscience Ltd.

List of Tables

• Table 1 List of abbreviation
• Table 2 North America Primary Cell Culture Market, Region, 2018 - 2030 (USD Million)
• Table 3 North America Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 4 North America Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 5 North America Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 6 North America Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 7 U.S. Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 8 U.S. Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 9 U.S. Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 10 U.S. Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 11 Canada Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 12 Canada Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 13 Canada Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 14 Canada Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 15 Europe Primary Cell Culture Market, Region, 2018 - 2030 (USD Million)
• Table 16 Europe Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 17 Europe Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 18 Europe Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 19 Europe Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 20 UK Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 21 UK Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 22 UK Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 23 UK Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 24 Germany Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 25 Germany Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 26 Germany Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 27 Germany Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 28 France Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 29 France Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 30 France Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 31 France Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 32 Italy Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 33 Italy Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 34 Italy Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 35 Italy Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 36 Spain Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 37 Spain Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 38 Spain Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 39 Spain Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 40 Sweden Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 41 Sweden Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 42 Sweden Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 43 Sweden Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 44 Norway Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 45 Norway Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 46 Norway Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 47 Norway Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 48 Denmark Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 49 Denmark Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 50 Denmark Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 51 Denmark Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific Primary Cell Culture Market, Region, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 57 Japan Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 58 Japan Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 59 Japan Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 60 Japan Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 61 China Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 62 China Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 63 China Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 64 China Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 65 India Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 66 India Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 67 India Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 68 India Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 69 Australia Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 70 Australia Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 71 Australia Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 72 Australia Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 73 South Korea Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 74 South Korea Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 75 South Korea Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 76 South Korea Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 77 Thailand Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 78 Thailand Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 79 Thailand Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 80 Thailand Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 81 Latin America Primary Cell Culture Market, Region, 2018 - 2030 (USD Million)
• Table 82 Latin America Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 83 Latin America Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 84 Latin America Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 85 Latin America Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 86 Brazil Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 87 Brazil Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 88 Brazil Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 89 Brazil Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 90 Mexico Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 91 Mexico Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 92 Mexico Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 93 Mexico Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 94 Argentina Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 95 Argentina Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 96 Argentina Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 97 Argentina Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 98 MEA Primary Cell Culture Market, Region, 2018 - 2030 (USD Million)
• Table 99 MEA Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 100 MEA Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 101 MEA Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 102 MEA Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 103 South Africa Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 104 South Africa Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 105 South Africa Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 106 South Africa Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 111 UAE Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 112 UAE Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 113 UAE Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 114 UAE Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)
• Table 115 Kuwait Primary Cell Culture Market, By Product, 2018 - 2030 (USD Million)
• Table 116 Kuwait Primary Cell Culture Market, By Separation Method, 2018 - 2030 (USD Million)
• Table 117 Kuwait Primary Cell Culture Market, By Cell Type, 2018 - 2030 (USD Million)
• Table 118 Kuwait Primary Cell Culture Market, By Application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Techniques
• Fig. 3 Primary Research Pattern
• Fig. 4 Primary Interviews in North America
• Fig. 5 Primary Interviews in Europe
• Fig. 6 Primary Interviews in APAC
• Fig. 7 Primary Interviews in Latin America
• Fig. 8 Primary Interviews in MEA
• Fig. 9 Market Research Approaches
• Fig. 10 Value-Chain-Based Sizing & Forecasting
• Fig. 11 QFD Modeling for Market Share Assessment
• Fig. 12 Market Formulation & Validation
• Fig. 13 Primary Cell Culture Market: Market Outlook
• Fig. 14 Primary Cell Culture Competitive Insights
• Fig. 15 Parent Market Outlook
• Fig. 16 Related/Ancillary Market Outlook
• Fig. 17 Penetration and Growth Prospect Mapping
• Fig. 18 Industry Value Chain Analysis
• Fig. 19 Primary Cell Culture Market Driver Impact
• Fig. 20 Primary Cell Culture Market Restraint Impact
• Fig. 21 Primary Cell Culture Market Strategic Initiatives Analysis
• Fig. 22 Primary Cell Culture Market: Product Movement Analysis
• Fig. 23 Primary Cell Culture Market: Product Outlook and Key Takeaways
• Fig. 24 Primary Cells Market Estimates and Forecast, 2018 - 2030
• Fig. 25 Reagents & Supplements Market Estimates and Forecast, 2018 - 2030
• Fig. 26 Media Market Estimates and Forecast, 2018 - 2030
• Fig. 27 Primary Cell Culture Market: Separation Method Movement Analysis
• Fig. 28 Primary Cell Culture Market: Separation Method Outlook and Key Takeaways
• Fig. 29 Explant Method Market Estimates and Forecasts, 2018 - 2030
• Fig. 30 Enzymatic Degradation Market Estimates and Forecasts, 2018 - 2030
• Fig. 31 Mechanical Separation Market Estimates and Forecasts, 2018 - 2030
• Fig. 32 Others Market Estimates and Forecasts, 2018 - 2030
• Fig. 33 Primary Cell Culture Market: Cell Type Movement Analysis
• Fig. 34 Primary Cell Culture Market: Cell Type Outlook and Key Takeaways
• Fig. 35 Animal Cells Market Estimates and Forecasts, 2018 - 2030
• Fig. 36 Human Cells Market Estimates and Forecasts, 2018 - 2030
• Fig. 37 Primary Cell Culture Market: Application Movement Analysis
• Fig. 38 Primary Cell Culture Market: Application Outlook and Key Takeaways
• Fig. 39 Cell & Gene Therapy Development Market Estimates and Forecasts, 2018 - 2030
• Fig. 40 Cardiovascular Market Estimates and Forecasts, 2018 - 2030
• Fig. 41 Vaccine Production Market Estimates and Forecasts, 2018 - 2030
• Fig. 42 Model System Market Estimates and Forecasts, 2018 - 2030
• Fig. 43 Virology Market Estimates and Forecasts, 2018 - 2030
• Fig. 44 Prenatal Diagnosis Market Estimates and Forecasts, 2018 - 2030
• Fig. 45 Others Market Estimates and Forecasts, 2018 - 2030
• Fig. 46 Primary Cell Culture Market: Application Movement Analysis
• Fig. 47 Primary Cell Culture Market: Application Outlook and Key Takeaways
• Fig. 48 Pharmaceuticals Market Estimates and Forecasts, 2018 - 2030
• Fig. 49 Biologicals Market Estimates and Forecasts, 2018 - 2030
• Fig. 50 Medical Device Market Estimates and Forecasts, 2018 - 2030
• Fig. 51 Global Primary Cell Culture Market: Regional Movement Analysis
• Fig. 52 Global Primary Cell Culture Market: Regional Outlook and Key Takeaways
• Fig. 53 Global Primary Cell Culture Market Share and Leading Players
• Fig. 54 North America Market Share and Leading Players
• Fig. 55 Europe Market Share and Leading Players
• Fig. 56 Asia Pacific Market Share and Leading Players
• Fig. 57 Latin America Market Share and Leading Players
• Fig. 58 Middle East & Africa Market Share and Leading Players
• Fig. 59 North America: SWOT
• Fig. 60 Europe: SWOT
• Fig. 61 Asia Pacific: SWOT
• Fig. 62 Latin America: SWOT
• Fig. 63 MEA: SWOT
• Fig. 64 North America, By Country
• Fig. 65 North America
• Fig. 66 North America Market Estimates and Forecasts, 2018 - 2030
• Fig. 67 U.S.
• Fig. 68 U.S. Market Estimates and Forecasts, 2018 - 2030
• Fig. 69 Canada
• Fig. 70 Canada Market Estimates and Forecasts, 2018 - 2030
• Fig. 71 Europe
• Fig. 72 Europe Market Estimates and Forecasts, 2018 - 2030
• Fig. 73 UK
• Fig. 74 UK Market Estimates and Forecasts, 2018 - 2030
• Fig. 75 Germany
• Fig. 76 Germany Market Estimates and Forecasts, 2018 - 2030
• Fig. 77 France
• Fig. 78 France Market Estimates and Forecasts, 2018 - 2030
• Fig. 79 Italy
• Fig. 80 Italy Market Estimates and Forecasts, 2018 - 2030
• Fig. 81 Spain
• Fig. 82 Spain Market Estimates and Forecasts, 2018 - 2030
• Fig. 83 Denmark
• Fig. 84 Denmark Market Estimates and Forecasts, 2018 - 2030
• Fig. 85 Sweden
• Fig. 86 Sweden Market Estimates and Forecasts, 2018 - 2030
• Fig. 87 Norway
• Fig. 88 Norway Market Estimates and Forecasts, 2018 - 2030
• Fig. 89 Asia Pacific
• Fig. 90 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
• Fig. 91 China
• Fig. 92 China Market Estimates and Forecasts, 2018 - 2030
• Fig. 93 Japan
• Fig. 94 Japan Market Estimates and Forecasts, 2018 - 2030
• Fig. 95 India
• Fig. 96 India Market Estimates and Forecasts, 2018 - 2030
• Fig. 97 Thailand
• Fig. 98 Thailand Market Estimates and Forecasts, 2018 - 2030
• Fig. 99 South Korea
• Fig. 100 South Korea Market Estimates and Forecasts, 2018 - 2030
• Fig. 101 Australia
• Fig. 102 Australia Market Estimates and Forecasts, 2018 - 2030
• Fig. 103 Latin America
• Fig. 104 Latin America Market Estimates and Forecasts, 2018 - 2030
• Fig. 105 Brazil
• Fig. 106 Brazil Market Estimates and Forecasts, 2018 - 2030
• Fig. 107 Mexico
• Fig. 108 Mexico Market Estimates and Forecasts, 2018 - 2030
• Fig. 109 Argentina
• Fig. 110 Argentina Market Estimates and Forecasts, 2018 - 2030
• Fig. 111 Middle East and Africa
• Fig. 112 Middle East and Africa Market Estimates And Forecasts, 2018 - 2030
• Fig. 113 South Africa
• Fig. 114 South Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 115 Saudi Arabia
• Fig. 116 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
• Fig. 117 UAE
• Fig. 118 UAE Market Estimates and Forecasts, 2018 - 2030
• Fig. 119 Kuwait
• Fig. 120 Kuwait Market Estimates and Forecasts, 2018 - 2030
• Fig. 121 Market Share Of Key Market Players- Primary Cell Culture Market

Primary Cell Culture Market Growth & Trends:

The global primary cell culture market size is expected to reach USD 11.59 billion by 2030, expanding at a CAGR of 13.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for personalized and precision therapies has fueled the need for more accurate and relevant in vitro models. Primary cell culture provides a closer representation of human biology and physiology compared to traditional cell lines, making it an indispensable tool for studying disease mechanisms, drug discovery, and therapeutic development. Researchers and pharmaceutical companies are increasingly recognizing the importance of primary cell culture for improving the success rates of drug candidates, reducing costly late-stage failures, and ultimately delivering more effective and targeted treatments to patients.

Moreover, the field of regenerative medicine aims to replace or repair damaged tissues and organs, and primary cell culture plays a vital role in developing and engineering functional tissues. Primary cells are used to create tissue constructs, organoids, and bioengineered implants that closely mimic the structure and function of native tissues. These advancements have significant implications for regenerative medicine therapies, including tissue transplantation, wound healing, and the treatment of degenerative diseases. For instance, in April 2023, Mount Sinai launched a new institute for regenerative medicine to foster novel discoveries and explore new therapies for life-threatening diseases. The growing interest in regenerative medicine and the potential to revolutionize healthcare have led to increased investment and research in primary cell culture, propelling the market's growth.

The COVID-19 pandemic has significantly impacted the primary cell culture industry. While the pandemic disrupted various industries, including healthcare and research, it highlighted the crucial role of primary cell culture in understanding viruses and developing treatments. Primary cells have been instrumental in studying the mechanisms of SARS-CoV-2 infection, testing antiviral therapies, and evaluating vaccine efficacy. The pandemic has accelerated the demand for primary cell culture products and services as researchers worldwide focused on COVID-19-related studies.

Furthermore, several developments undertaken by key market participants, and increasing industry-academia collaborations are driving the global market. For instance, in January 2023, Bio-Trac and ATCC collaborated to conduct a training workshop to offer an overview of the principles of primary cell culture, organoids and spheroids, and other related cell culture techniques.

Primary Cell Culture Market Report Highlights:

• By product, the reagent and supplements segment dominated with a share of 37.7% in 2023, due availability of a wide range of high-quality reagents and supplements tailored for specific cell types and research applications
• By separation method, the enzymatic degradation segment dominated the market with a share of 32.15% in 2023, due to the advantages of this method such as less damage to cultures, a relatively short turnaround time, and a high output of sample representation
• By cell type, the animal cells segment dominated the market with a share of 59.41% in 2022. The high growth of the segment is attributed to the versatility, wide availability, and established research protocols for this cell type
• North America established a strong regional position in the global market with a 41.52% share in 2023 due to its highly developed healthcare infrastructure and favorable government policies

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Product Segment
    • 1.1.1.2. Separation Method Segment
    • 1.1.1.3. Cell Type Segment
    • 1.1.1.4. Application segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Primary Sources
• 1.11. List of Abbreviations

Chapter 2. Primary Cell Culture Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Product and Separation Method Snapshots
• 2.3. Cell Type and Application Snapshot
• 2.4. Competitive Landscape Snapshot

Chapter 3. Primary Cell Culture Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers Analysis
  • 3.4.1. Rising usage of primary cell culture products in in-vitro testing and drug screening
  • 3.4.2. Increasing in demand for stem cell therapy and regenerative medicine
  • 3.4.3. Rising incidence of cancer and other chronic diseases
  • 3.4.4. Advancement in genetic engineering protocols
  • 3.4.5. Rise in research funding for functional biology and research
• 3.5. Market Restraint Analysis
  • 3.5.1. Ethical and regulatory concerns related to the use of primary cells
  • 3.5.2. Finite Lifespan, slow growth and critical to handle
• 3.6. Primary Cell Culture Market Analysis Tools
  • 3.6.1. Industry Analysis - Porter's
    • 3.6.1.1. Supplier Power
    • 3.6.1.2. Buyer Power
    • 3.6.1.3. Substitution Threat
    • 3.6.1.4. Threat of New Entrant
    • 3.6.1.5. Competitive Rivalry
  • 3.6.2. PESTLE Analysis
    • 3.6.2.1. Political Landscape
    • 3.6.2.2. Technological Landscape
    • 3.6.2.3. Economic Landscape

Chapter 4. Primary Cell Culture: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Primary Cell Culture Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analysis, 2018 - 2030 For The Following
  • 4.4.1. Primary Cells
    • 4.4.1.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.1.1.1. Fat Cells
    • 4.4.1.1.1.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.1.1.2. Blood Cells
    • 4.4.1.1.2.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.1.1.3. Nerve Cells
    • 4.4.1.1.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.1.1.4. Bone Cells
    • 4.4.1.1.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.1.1.5. Endothelial Cells
    • 4.4.1.1.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.1.1.6. Skin Cells
    • 4.4.1.1.6.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.1.1.7. Muscle Cells
    • 4.4.1.1.7.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.1.1.8. Other Cells
    • 4.4.1.1.8.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 4.4.2. Reagents and Supplements
    • 4.4.2.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.2.1.1. Attachment Solutions
    • 4.4.2.1.1.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.2.1.2. Buffers and Salts
    • 4.4.2.1.2.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.2.1.3. Sera
    • 4.4.2.1.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.2.1.4. Growth Factors and Cytokines
    • 4.4.2.1.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.2.1.5. Others
    • 4.4.2.1.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 4.4.3. Media
    • 4.4.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.1. Fat Cells Media
    • 4.4.3.1.1.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.2. Blood Cells Media
    • 4.4.3.1.2.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.3. Nerve Cells Media
    • 4.4.3.1.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.4. Bone Cells Media
    • 4.4.3.1.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.5. Endothelial Cells Media
    • 4.4.3.1.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.6. Skin Cells Media
    • 4.4.3.1.6.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.7. Muscle Cells Media
    • 4.4.3.1.7.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.8. Stem Cells Media
    • 4.4.3.1.8.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 4.4.3.1.9. Others
    • 4.4.3.1.9.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)

Chapter 5. Primary Cell Culture: Separation Method Estimates & Trend Analysis

• 5.1. Separation Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Primary Cell Culture Market by Separation Method Outlook
• 5.4. Market Size & Forecasts and Trend Analysis, 2018 - 2030 For The Following
  • 5.4.1. Explant Method
    • 5.4.1.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 5.4.2. Enzymatic Degradation
    • 5.4.2.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.1. Trypsin
    • 5.4.2.1.1.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.2. Collagenase
    • 5.4.2.1.2.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.3. Protease
    • 5.4.2.1.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.4. Pronase
    • 5.4.2.1.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.5. Dispane
    • 5.4.2.1.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.6. Hyaluronidase
    • 5.4.2.1.6.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.7. Neuraminidase
    • 5.4.2.1.7.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.8. Elastase
    • 5.4.2.1.8.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.9. DNase
    • 5.4.2.1.9.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.10. Papain
    • 5.4.2.1.10.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.11. Accutase
    • 5.4.2.1.11.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 5.4.2.1.12. Others
    • 5.4.2.1.12.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 5.4.3. Mechanical Separation
    • 5.4.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)

Chapter 6. Primary Cell Culture: Cell Type Estimates & Trend Analysis

• 6.1. Cell Type Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Primary Cell Culture Market by Cell Type Outlook
• 6.4. Market Size & Forecasts and Trend Analysis, 2018 - 2030 For The Following
  • 6.4.1. Animal Cells
    • 6.4.1.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 6.4.2. Human Cells
    • 6.4.2.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)

Chapter 7. Primary Cell Culture: Application Estimates & Trend Analysis

• 7.1. Application Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Primary Cell Culture Market by Application Area Outlook
• 7.4. Market Size & Forecasts and Trend Analysis, 2018 - 2030 For The Following
  • 7.4.1. Cell & Gene Therapy Development
    • 7.4.1.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.4.2. Vaccine Production
    • 7.4.2.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.4.3. Model System
    • 7.4.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.4.4. Virology
    • 7.4.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.4.5. Prenatal Diagnosis
    • 7.4.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.4.6. Others
    • 7.4.6.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Marker Size, & Forecasts Trend Analysis, 2018 - 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key Country Dynamics
    • 8.5.1.2. Competitive Scenario
    • 8.5.1.3. Regulatory Framework
    • 8.5.1.4. U.S. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Canada Market Estimates and Forecasts 2018 - 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key Country Dynamics
    • 8.6.1.2. Competitive Scenario
    • 8.6.1.3. Regulatory Framework
    • 8.6.1.4. UK Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Germany Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.6.3. Spain
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Spain Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. France Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Italy Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.6.6. Denmark
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Denmark Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 8.6.6.5.
  • 8.6.7. Sweden
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Sweden Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.6.8. Norway
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Competitive Scenario
    • 8.6.8.3. Regulatory Framework
    • 8.6.8.4. Norway Market Estimates and Forecasts 2018 - 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key Country Dynamics
    • 8.7.1.2. Competitive Scenario
    • 8.7.1.3. Regulatory Framework
    • 8.7.1.4. Japan Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. China Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. India Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.7.4. South Korea
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. South Korea Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.7.5. Thailand
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Thailand Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.7.6. Australia
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Australia Market Estimates and Forecasts 2018 - 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key Country Dynamics
    • 8.8.1.2. Competitive Scenario
    • 8.8.1.3. Regulatory Framework
    • 8.8.1.4. Brazil Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.8.2. Mexico
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. Mexico Primary Cell Culture Market, 2018 - 2030 (USD Million)
  • 8.8.3. Argentina
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Argentina Market Estimates and Forecasts 2018 - 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. MEA Primary Cell Culture Market, 2018 - 2030 (USD Million)
  • 8.9.2. South Africa
    • 8.9.2.1. Key Country Dynamics
    • 8.9.2.2. Competitive Scenario
    • 8.9.2.3. Regulatory Framework
    • 8.9.2.4. South Africa Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.9.3. Saudi Arabia
    • 8.9.3.1. Key Country Dynamics
    • 8.9.3.2. Competitive Scenario
    • 8.9.3.3. Regulatory Framework
    • 8.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.9.4. UAE
    • 8.9.4.1. Key Country Dynamics
    • 8.9.4.2. Competitive Scenario
    • 8.9.4.3. Regulatory Framework
    • 8.9.4.4. UAE Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 8.9.5. Kuwait
    • 8.9.5.1. Key Country Dynamics
    • 8.9.5.2. Competitive Scenario
    • 8.9.5.3. Regulatory Framework
    • 8.9.5.4. Kuwait Market Estimates and Forecasts 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company /Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of Key Distributors And Channel Partners
  • 9.3.2. Key Customers
  • 9.3.3. Key Company Market Share Analysis, 2023
  • 9.3.4. Thermo Fisher Scientific, Inc.
    • 9.3.4.1. Overview
    • 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Lonza
    • 9.3.5.1. Overview
    • 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Merck
    • 9.3.6.1. Overview
    • 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Corning Incorporated
    • 9.3.7.1. Overview
    • 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Danaher
    • 9.3.8.1. Overview
    • 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. PromoCell GmbH
    • 9.3.9.1. Overview
    • 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. ATCC
    • 9.3.10.1. Overview
    • 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. FUJIFILM Irvine Scientific, Inc.
    • 9.3.11.1. Overview
    • 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.11.3. Product Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. Mattek
    • 9.3.12.1. Overview
    • 9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.12.3. Product Benchmarking
    • 9.3.12.4. Strategic Initiatives
  • 9.3.13. Axol Bioscience Ltd.
    • 9.3.13.1. Overview
    • 9.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.13.3. Product Benchmarking
    • 9.3.13.4. Strategic Initiatives